What is the safe dose of meperidine (Demerol) for adults and children?

Safe Dose of Meperidine (Demerol)

For adults, the safe dose of meperidine is 50-150 mg intramuscularly or subcutaneously every 3-4 hours, and for children, 0.5-0.8 mg/lb (1.1-1.8 mg/kg) up to the adult dose every 3-4 hours, though meperidine should generally be avoided due to poor efficacy and significant toxicity risks. 1

Adult Dosing

According to the FDA label, standard dosing for pain relief in adults is 1:

• 50-150 mg IM or subcutaneous every 3-4 hours
• Elderly patients should receive doses at the lower end of this range
• If IV administration is required, reduce the dose by 25-50% and inject very slowly using a diluted solution
• When combined with phenothiazines or tranquilizers, reduce meperidine dose by 25-50%

Critical Safety Thresholds for Adults

The maximum safe dose is 10 mg/kg per day for no longer than 3 days when using patient-controlled analgesia 2. Research demonstrates that:

• Patients receiving less than 10 mg/kg/day were unlikely to experience CNS excitatory adverse effects
• Those receiving more than 600 mg/day had increased risk of toxicity 3, 2
• Patients consuming 16.9 mg/kg/day had significantly higher rates of CNS toxic reactions compared to 13.3 mg/kg/day 2
• The incidence of CNS toxic reactions with IV PCA was 2% 2

Pediatric Dosing

For children, the FDA-approved dosing is 1:

• 0.5-0.8 mg/lb (1.1-1.8 mg/kg) IM or subcutaneous every 3-4 hours, up to adult dose
• For preoperative medication: 0.5-1 mg/lb (1.1-2.2 mg/kg), 30-90 minutes before anesthesia

Pediatric Safety Considerations

Research on pediatric dosing reveals important safety concerns:

• A dose-response study found 1.0 mg/lb (2.2 mg/kg) IM was associated with significantly more nausea, vomiting, and transient drops in oxygen saturation compared to lower doses 4
• The 0.5 mg/lb (1.1 mg/kg) dose was effective with fewer side effects 4
• When meperidine is used in combination (DPT cocktail), respiratory depression occurred even at recommended or lower doses, with one patient developing respiratory arrest at 0.07 ml/kg 5

Critical Warnings and Contraindications

The 2021 SPAQI consensus strongly recommends against meperidine use 3:

Avoid meperidine entirely in:

• Renal insufficiency (GFR <30 mL/min/1.73 m²) or ESRD - accumulation of toxic metabolite normeperidine 3
• Patients taking MAO inhibitors, SSRIs, or other serotonergic/noradrenergic medications - risk of serotonin syndrome 3
• Patients with acute or underlying neurologic abnormalities - significantly increased complication risk 6

Key toxicity concerns:

• Normeperidine, the active metabolite, has a half-life of 15-30 hours and causes CNS excitation, tremors, myoclonus, and seizures 7, 8
• Duration of use should not exceed 48 hours and total dose should not exceed 600 mg/24 hours per ISMP warnings 9
• Daily patient evaluation is mandatory when meperidine is used 2

Why Meperidine Should Be Avoided

The evidence overwhelmingly supports avoiding meperidine as a first-line analgesic 3, 10, 8:

• A 2020 comprehensive review of 62 randomized controlled trials found meperidine had similar or inferior analgesic efficacy compared to other opioids and was associated with more sedation and respiratory depression 10
• Meperidine offers no therapeutic advantage over other opioids for any indication, including the commonly cited uses for biliary colic or pancreatitis 8
• The drug has poor oral bioavailability, multiple drug interactions, and produces a neurotoxic metabolite 7
• Meperidine should be considered a second-line agent only when other opioid analgesics are contraindicated 7

Practical Recommendations

If meperidine must be used despite these warnings:

• Limit to maximum 600 mg/24 hours for maximum 48 hours 9
• Use 10 mg/kg/day as absolute maximum 2
• Monitor respiratory rate, oxygen saturation, and mental status frequently
• Avoid in elderly, renally impaired, or neurologically compromised patients
• Consider the perioperative period as an opportunity to transition patients to safer alternatives like hydromorphone, fentanyl, or morphine 3

The consensus recommendation is to use alternative opioids (morphine, hydromorphone, fentanyl, oxycodone) that lack neurotoxic metabolites and have superior safety profiles 3, 10, 8.